Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12582407.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a patient with widespread and progressive cutaneous sarcoidosis who was successfully treated with anti-tumor necrosis factor-alpha monoclonal antibody, infliximab, suggesting that inhibition of tumor necrosis factor-alpha may be useful as targeted treatment in cutaneous sarcoidosis.
Medical subject headings
- Antibodies, Monoclonal
- Dermatologic Agents
- Sarcoidosis
- Skin Diseases